#Pharmaceutical Marketing Practices 2024
Explore tagged Tumblr posts
Text
Govt releases guidelines to curb unethical pharma sector practices
Stay informed on the Dept. of Pharmaceuticals' new Uniform Code for Pharmaceutical Marketing Practices 2024 & guidelines on gifts & benefits to curb unethical conduct.
#Pharmaceutical Marketing Practices 2024#guidelines on gifts & benefits#prevent unethical practices#Counterfeit Drugs and Supply Chain Integrity#guidelines to curb unethical pharma sector practices
0 notes
Text
![Tumblr media](https://64.media.tumblr.com/dd49cbc1280b3ba3095f0de491f2c542/8389fbeba96c73fa-c6/s540x810/386d8296b8d8fc528f3d6280e6f4aa4c4c92c06e.jpg)
William Faulkner, "Never be afraid" :: [(From a speech delivered May 28, 1951 at Fulton Chapel, University of Mississippi)]
* * * *
LETTERS FROM AN AMERICAN
September 25, 2024
Heather Cox Richardson
Sep 26, 2024
In 2004 a senior advisor to President George W. Bush famously told journalist Ron Suskind that people like Suskind lived in “the reality-based community.” They believed people could find solutions to problems through careful study of discernible reality. But, the aide continued, Suskind’s worldview was obsolete. “That’s not the way the world really works anymore,” the aide said. “We are an empire now, and when we act, we create our own reality. And while you’re studying that reality— judiciously, as you will—we’ll act again, creating other new realities, which you can study too, and that’s how things will sort out. We’re history’s actors…and you, all of you, will be left to just study what we do.”
We appear to be in a moment when the reality-based community is challenging the ability of the MAGA Republicans to create their own reality.
Central to the worldview of MAGA Republicans is that Democrats are socialists who have destroyed the American economy. Trump calls Harris a “radical-left. Marxist, communist, fascist” and insists the economy is failing.
In Pittsburgh, Pennsylvania, today, Harris laid out her three-pillar plan for an “opportunity economy.” She explained that she would lower costs by cutting taxes for the middle class, cutting the red tape that stops housing construction, take on corporate landlords who are hiking rental prices, work with builders and developers to construct 3 million new homes and rentals, and help first-time homebuyers with $25,000 down payment assistance. She also promised to enact a federal ban on corporate price gouging on groceries and to cap prescription drug prices by negotiating with pharmaceutical companies.
Harris said she plans to invest in innovation by raising the deduction for startup businesses from its current $5,000 to $50,000 and providing low- or no-interest loans to small businesses that want to expand. Her goal is to open the way for 25 million new small businesses in her first four years, noting that small businesses create nearly 50% of private sector jobs in the U.S.
Harris plans to create manufacturing jobs of the future by investing in biomanufacturing and aerospace, remaining “dominant in AI, quantum computing, blockchain, and other emerging technologies, and expand[ing] our lead in clean energy innovation and manufacturing.” She vowed to see that the next generation of breakthroughs—“from advanced batteries to geothermal to advanced nuclear—are not just invented, but built here in America by American workers.” Investing in these industries means strengthening factory towns, retooling existing factories, hiring locally, and working with unions. She vowed to make jobs available for skilled workers without college degrees and to cut red tape to reform permitting for innovation.
“I am a capitalist,” she said. “I believe in free and fair markets. I believe in consistent and transparent rules of the road to create a stable business environment. And I know the power of American innovation.” She said she would be pragmatic in her approach to the economy, seeking practical solutions to problems and taking good ideas from wherever they come.
“Kamala Harris, Reagan Democrat!” conservative pundit Bill Kristol posted on social media after her speech.
For his part, Trump has promised an across-the-board tariff of 10% to 20% that billionaire Mark Cuban on the Fox News Channel called “insane” and Quin Hillyer of the Washington Examiner warned “would almost certainly cause immense price hikes domestically, goad other countries into retaliating, and perhaps set off an international trade war” that could “wreck the economy.” Cuban then told Jake Tapper of CNN that Trump’s promise to impose 10% price controls on credit card interest rates and price caps is “Socialism 101.”
Yesterday, more than 400 economists and high-ranking U.S. policymakers endorsed Harris, and today, the members of former South Carolina governor Nikki Haley’s presidential leadership teams in Michigan, Iowa, and Vermont announced they would be supporting Harris, in part because of Trump’s economic policies.
While Trump insisted yet again today that “the economy is doing really, really badly,” the stock market closed at a record high today for the fourth day in a row.
In other economic news, for nine years, Trump has said he will find a cheaper and better way to provide healthcare to Americans than the Affordable Care Act, although on September 10 he admitted he has only the “concepts of a plan.” Today the Treasury Department released statistics showing that 4.2 million small business owners have coverage through the ACA. Losing that protection would impact 618,590 small business owners in Florida, 450,010 in California, 423,790 in Texas, and 168,070 in Georgia.
Trump has made a claim that crime has risen dramatically under President Joe Biden and Vice President Kamala Harris central to his campaign rhetoric. The opposite is true. Two days ago, on September 23, the Federal Bureau of Investigation released its official report on crime statistics from 2023 compared with 2022. Those statistics showed that murder and non-negligent manslaughter fell by 11.6%. Rape fell by 9.4%. Aggravated assault fell by 2.8%. Robbery fell by 0.3%. Hate crimes fell by 0.6%.
Central to the worldview of MAGA Republicans is that immigration weakens a nation and that immigrants increase crime and disease. First Republican vice presidential nominee Ohio senator J.D. Vance and then Trump himself repeatedly advanced the lie that Haitian immigrants in Springfield, Ohio, are eating their neighbors’ pets and bringing disease.
Clergy members from multiple faiths have asked politicians to stop their lies about Haitian immigrants, and today the leader of Haitian Bridge Alliance, a nonprofit organization that represents the Haitian community, filed a charges against Trump and Vance for disrupting public services, making false alarms, telecommunications harassment, and aggravated menacing and complicity.
Immediately, Representative Clay Higgins (R-LA), who in the past supported Ku Klux Klan leader David Duke and filmed a selfie inside a gas chamber at Auschwitz, posted on social media: “Lol. These Haitians are wild. Eating pets, vudu, nastiest country in the western hemisphere, cults, slapstick gangsters…but damned if they don’t feel all sophisticated now, filing charges against our President and VP. All these thugs better get their mind right and their *ss out of our country before January 20th.”
After an outcry, Higgins took the post down. According to House speaker and fellow Louisiana Republican Mike Johnson, who called Higgins a “very principled man,” Higgins took it down after he “prayed about it.” Johnson seemed unconcerned about his colleague’s racism, saying, “we believe in redemption around here.”
But in a statement, House minority leader Hakeem Jeffries (D-NY) called Higgins’s statement “vile, racist and beneath the dignity of the United States House of Representatives. He must be held accountable for dishonorable conduct that is unbecoming of a Member of Congress. Clay Higgins is an election-denying, conspiracy-peddling racial arsonist who is a disgrace to the People’s House. This is who they have become. Republicans are the party of Donald Trump, Mark Robinson, Marjorie Taylor Greene, Clay Higgins and Project 2025. The extreme MAGA Republicans in the House are unfit to govern.”
On Monday, Dan Gooding of Newsweek reported that although Trump said on September 18 he would go to Springfield, he will not. Republican Ohio governor Mike DeWine had warned that the local community would not welcome a visit from the former president.
Republican politicians and candidates, including Trump, embraced North Carolina gubernatorial candidate and current lieutenant governor Mark Robinson, who trumpeted the extremists’ MAGA narrative. The September 19 revelation by CNN reporters Andrew Kaczynski and Em Steck that Robinson had boasted on a pornography website that he considers himself a “black NAZI!”, would like to reinstate slavery, and would like to own some people himself, and shared the sexual kinks in which he engaged with his wife’s sister prompted most of his campaign staff to resign.
Andrew Egger of The Bulwark reported today that on a different online forum, Robinson called for a political assassination as well as making racist attacks on entertainer Oprah Winfrey and former president Barack Obama. Robinson has called all the information released about him “false smears” and has said “[n]ow is not the time for intra-party squabbling and nonsense,” but declined help tracking down those he claims falsified his online comments. Today, multiple media outlets reported that top staff in Robinson’s government office are stepping down.
Reality hit hard this week in Texas, too, where U.S. Bankruptcy Judge Christopher Lopez yesterday approved the auctioning off of conspiracy theorist Alex Jones’s media business, the aptly-named InfoWars. Jones insisted that the 2012 Sandy Hook Elementary School shooting was a “hoax” designed to whip up support for gun restrictions, and that the grieving parents were played by “crisis actors.” Juries found Jones guilty of defaming the families of the murdered children and causing them emotional distress.
The auction of his property will enable the families to begin to collect on the more than $1 billion the jurors determined Jones owed them for his reprehensible and harmful behavior.
LETTERS FROM AN AMERICAN
HEATHER COX RICHARDSON
#Letters From An American#Heather Cox Richardson#election 2024#William Faulkner#quotes#MAGA poison#racism#Mark Robinson#Clay Higgins#the economy#the middle class
21 notes
·
View notes
Text
By: Christina Buttons
Published: Dec 11, 2024
In interviews, I’ve often shared how I became a journalist after discovering the stories of detransitioners—stories that deeply resonated with my own struggles with mental health and identity. I’ve been very open about the severe mental health crises I faced in my youth and have frequently alluded to the "bad decisions" I made as a young adult. As my public profile grew, I was prepared for the inevitability that those bad decisions would become known. Now that they have, I want to use this moment to share my story in the hope that it can be instructive and bring attention to an issue I believe is preventing many from recovering from mental illness.
There’s been much speculation about the ongoing youth mental health crisis, particularly about why liberals—especially liberal girls—report the highest rates of mental illness. Some have suggested that locus of control plays a contributing role. Those with an external locus of control, who believe their lives are shaped by forces beyond their control, tend to be less mentally well and lean more liberal. In contrast, those with an internal locus of control, who believe they have agency over their lives, are generally mentally healthier and more likely to align with conservative values.
This idea resonates deeply with me and my own experiences, and I want to expand on it. I believe young people, especially liberals, are constantly bombarded with messages that reinforce an external locus of control. This concept is central to the book I am writing, where I lay out the origins of this mindset and the effect it has on people. A significant contributor is the brain disease model of mental illness. This biomedical model, which portrays mental illness as a medical condition, profoundly shaped my sense of self growing up and, I believe, continues to influence how many young people perceive themselves and their struggles.
The Brain Disease Model of Mental Illness
In the 1980s, psychiatry sought to establish itself as a legitimate branch of scientific medicine by adopting a biomedical model, which framed mental disorders as brain diseases. This approach offered a straightforward explanation: mental illnesses result from biological dysfunctions, such as chemical imbalances, and require medical treatment. One of the most influential narratives born from this model was the serotonin theory of depression, which claimed that depression was caused by low levels of serotonin in the brain.
Endorsed by professional organizations like the American Psychiatric Association (APA), the National Institute of Mental Health (NIMH), textbooks, and influential research papers, the brain disease model of mental disorders became a cornerstone of psychiatric practice and public understanding for 40 years. Pharmaceutical companies spent billions on advertising campaigns promoting psychotropic drugs as solutions to chemical imbalances. Public awareness initiatives claimed it would reduce stigma surrounding mental illness. As a result, surveys find that 80–90% of people believe depression is caused by a chemical imbalance.
However, this narrative was built more on marketing than science. Billions of dollars in neuroscience research over decades have failed to uncover clear and convincing evidence for a biological basis for mental disorders. The serotonin theory of depression, in particular, lacked substantial evidence and was debunked in 2022 by a systematic umbrella review. Despite this, there has been no major effort to correct public misconceptions or hold accountable those who promoted this idea without evidence.
The chemical imbalance theory remains the dominant cultural narrative about depression in the United States. Many states are now incorporating mental health education into K-12 curricula, but depending on how this education is conducted, it could cause more harm than good. For example, a Minnesota curriculum for middle and high school students, developed by the pharma-funded advocacy group National Alliance on Mental Illness (NAMI), teaches that mental illnesses are "brain disorders," emphasizing that "Biology, not a character flaw, causes mental illness."
This is a vast oversimplification. While hereditary components and traits like neuroticism may predispose individuals to negative thinking or mental health challenges, they do not determine their fate. Yet, in my recent interviews with young adults in treatment for mental health crises, every one of them described their mental disorder as a chemical imbalance or brain condition. They attributed the actions that led them into treatment to their disorder, viewing it as a lifelong condition, which they lacked control over.
Given the ubiquity of the biomedical model, it should come as no surprise that mental disorders are among the leading causes of disability—costing the U.S. economy upwards of $280 billion annually. As of 2022, over one in five adults in the U.S.—59.3 million people—report a mental illness diagnosis. For adolescents aged 13–18, the rate is even higher, with an estimated 49.5%—nearly one in two—diagnosed.
The lead author of the 2022 systematic umbrella review, Joanna Moncrieff, stated that "telling people they have a brain abnormality, or some physical medical problem, is profoundly disempowering." She is absolutely right. Such messaging undermines a person’s sense of agency and is particularly harmful to young, developing minds.
As a teenager immersed in a mental health system rooted in the biomedical model, I internalized the belief that something was fundamentally wrong with my brain and that I lacked control over my behavior. My story is one of breaking free from the constraints of this medical framework, overcoming the mental health challenges it reinforced, and reclaiming a sense of personal agency over my life.
Tumultuous Teen Years
I received many diagnoses throughout my life, the most recent being Asperger's syndrome at age 30. While I remain skeptical of behaviorally-diagnosed conditions and mindful of confirmation bias, I can see, in hindsight, early signs from childhood that align with the traits ascribed to Asperger's. From a young age, my life was continually punctuated by one all-consuming interest after another. I struggled to make and maintain friendships, and spent most of my time alone and engaging in solitary activities like staring into puddles and overturning rocks to observe small life forms, catching tadpoles, arranging my toys in elaborate setups, and drawing.
I was rigid and found comfort in routines, rewatching the same VHS tapes or listening to the same cassettes on repeat. My eating habits were similarly fixed—I was a very picky eater, choosing the same plain foods every day. I was also particular about textures, always preferring soft, stretchy fabrics. Physically, I was clumsy and uncoordinated, and I was highly sensitive to my environment.
But the real trouble didn't begin until early adolescence, when my family moved to a new city and I started middle school. I was not socially successful and was teased by other kids. The rejection felt monumental, leading me to become increasingly self-critical and withdrawn. The noisy, chaotic areas where kids gathered were overwhelming, so I often sought refuge in teachers’ classrooms during breaks and lunch or found quiet, secluded spots to be alone.
I began experiencing feelings of body dysmorphia, becoming hyperfocused on my flaws. I wore the same baggy black sweatshirt and stretchy blue jeans every day. I thought I was hideous and hid my face behind a wall of hair. I developed dermatillomania, compulsively picking at my scalp, as a way to self-comfort.
In class, I would repetitively draw the same figures and faces, retreating into a fantasy world—first Sailor Moon, then The Legend of Zelda, then Lord of the Rings—to escape from reality. Sometimes, I became so overwhelmed that I would get up and walk out of class, only to be sent to the counselor’s office. They recommended to my parents that I see a therapist. After school, I would go straight to my room and draw the curtains. I spent countless hours on the computer, teaching myself to code and designing websites dedicated to whatever my current interest was.
In 2002, when I was 13, my 7-year-old neighbor Danielle van Dam was raped and killed by our 49-year-old neighbor, David Westerfield. It was a big event in our community, and it deeply affected me. I followed the trial closely and collected the newspaper clippings about the case. I developed insomnia and obsessive-compulsive habits: walking around the house at night, checking the locks over and over, and washing my hands until they were raw.
Entering highschool, my mental health further plummeted and my relationship with my parents deteriorated. I was 14 when I started carving up my body with knives and razor blades. My outward appearance started to reflect my darker inner world; I dyed my hair red and wore heavy eyeliner. I became anorexic, and at 5’8”, my lowest weight was under 100 pounds. My biceps showed brown discoloration from muscle wasting. I began feeling like it would be better if I died.
It was during a visit to the psychiatrist in 2003 that I received a diagnosis of major depressive disorder after a brief meeting reviewing a checklist of symptoms. This was the first time I heard depression described as a "chemical imbalance" in my brain. This explanation made me feel hopeless, as it implied that my brain was somehow defective—I was born with this condition, and had no power to change it. During that appointment, I made a long slice down my arm in the bathroom with a razor blade, resulting in an emergency room visit and my first stay in a psychiatric hospital.
![Tumblr media](https://64.media.tumblr.com/4d78172b6433936f65f4304dde09748e/68b7015ebcbac7d4-c8/s540x810/88d93a57a7767937b4e5cd8f9aa869949fda25e6.jpg)
In 2004, I was caught in a cycle of crises, repeatedly accessing emergency rooms, psychiatric hospitals, outpatient programs, and group homes. I received numerous diagnoses from different psychiatrists and was prescribed a range of high-dose psychotropic medications—including one that caused a life-threatening rash and another that required regular EKGs.
At every step, the idea that mental illness was a brain disease I suffered from, and would have for the rest of my life, was reinforced. The lexicon of the Diagnostic and Statistical Manual of Mental Disorders (DSM) shaped my worldview, and I became preoccupied with finding the "correct" diagnosis so that I could better understand myself. The way the adults in my life referred to me as "sick" and "mentally ill" and described my behavior as "out of control" influenced my self-perception, and I took on the role of a sick person.
Due to my extensive absences from high school, I had an Individualized Education Program (IEP). As part of the evaluation process, they conducted psychological testing and classroom observations. The evaluator’s notes documented my monotone voice, "limited eye contact," "flat affect," instances of "stumbling while walking and almost falling," and that “test results indicate a large number of atypical perceptual experiences.” They also noted "social immaturity," "significant inflexibility in her thinking," "difficulty identifying feelings," "tendency to express emotions indirectly and impulsively," and that “when the teacher used humor in the classroom, Christina did not smile or appear to respond in the same manner as her peers.”
I also received a near-perfect score on Raven’s Progressive Matrices, a nonverbal intelligence test that measures an individual’s ability to identify patterns—a result I later learned is common among individuals with Asperger’s. However, Asperger’s was largely viewed as a "boys' disorder" at the time and was not considered in my case. Instead, my IEP labeled my disability as “Emotionally Disturbed.”
As my behavior escalated and became increasingly risky, I began seeking out drugs and alcohol. Things took a drastic turn for the worse when an internet predator found me on Myspace and began grooming me. He was 47, and I was only 15. He had deceived me, and when I met him in person, he raped me. The emotional pain was so unbearable afterwards that I tried to hang myself.
From the emergency room, I was placed in another psychiatric hospital—but this time there was no going home afterward. It became clear to my parents that I needed a higher level of care than they could provide. After running away from two lower-security residential treatment facilities, flunking out of a wilderness program in Idaho, and several more psychiatric hospital stays, I arrived at my final destination: a lockdown psychiatric residential treatment center in Utah called Provo Canyon School, where I would live for a year.
While other kids were getting their learner’s permits, celebrating their sweet sixteens, and attending school dances, I was in treatment. It was an intense, highly structured behavior modification program with a level system I had to work through to achieve a high status. It wasn’t easy or enjoyable, but it was effective in helping me break free from the cycle of crisis so that I could safely return home. (This type of treatment is in decline—a topic I’m passionate about and have several upcoming articles addressing.)
As for my rapist, he served less than six months in jail. This type of crime carried lighter penalties 20 years ago. I later learned that he reoffended four years later with another underage girl. He's still on the sex offender registry.
Young Adulthood
Things were stable at home for a while, and I managed to complete my GED at 17, but my relationship with my parents remained strained. By 19, living at home was no longer an option, and I found myself on my own. A friend’s family offered me a temporary place to stay, but I didn't want to be a burden on them, so I quickly moved in with a boyfriend I had just met.
We had a roommate who eventually moved out, leaving me needing additional income to cover expenses. I began doing photoshoots, which were initially clothed. However, after I was let go from my job as a nanny, the shoots progressed to unclothed. My boyfriend at the time, who had stopped working, either encouraged it or didn’t discourage it. This period is difficult to recall, as I’ve tried hard to forget it.
When the relationship ended, he left the country, abandoning me with significant debt, unpaid rent, and lease-breaking fees from our apartment. Our former roommate, who was also on the lease, was forced to cover the apartment fees to protect her credit and threatened legal action against me, leaving me desperate to find money quickly.
I eventually agreed to meet with a representative from an agency that had been hounding me, which led to my decision to make adult films to pay off my debt. At the time, and for several months thereafter, I believed I had bipolar disorder. However, I later realized that the instability I felt stemmed from other factors, including heavy drinking. My behavior mirrored my sense of self-worth—I saw myself as a mentally ill, degenerate loser, and I acted accordingly.
I was purely in survival mode, with no one to call for help and without the kind of stability one typically needs to think about the future and consider how my choices would impact me later in life. I was also very naive, believing that the content would remain on obscure, paywalled websites, unaware that free porn sites were beginning to dominate the internet.
While I don’t judge others who have chosen to do sex work, I would strongly discourage anyone considering it, as my own experience was traumatic and soul-crushing. I decided to work with an agency because I thought it would be safer, but my last assignment proved otherwise. They sent me to a hotel room with a man with a camera who choked me, hurt me, and ignored my cries and pleas to stop. Even after that, the agency relentlessly pressured me to continue, but I was done. In three and a half weeks, I had made enough to pay off my debt. How the owners chose to distribute, repackage, and republish the content at later dates and under multiple titles was entirely beyond my control.
Getting Better
Afterwards, I worked as a freelance graphic artist, but I was still directionless, turning to dangerous combinations of drugs and alcohol. That changed when I was 22 and began working for an employer whose family became a surrogate family to me. He believed in me, saw potential I couldn’t see in myself, and encouraged me to go back to school. For the first time, someone expected more from me—he didn’t treat me like I was a sick person or try to take advantage of me.
He introduced me to science, which quickly became my all-consuming passion. He gave me books on skepticism and debunking pseudoscience, which I devoured, and we watched debates on atheism that taught me about argumentation and logical fallacies.
I used to feel like a passive witness to my own life, watching myself make one bad decision after another, driven by emotions and impulses I couldn’t control due to my underlying mental illness. I had never been taught to think critically or base my beliefs on evidence, like a scientist. Learning how to think critically—and applying those techniques to myself—was the turning point when everything began to change.
There’s a meme I like that says, “Anxiety is just conspiracy theories about yourself.” The key is learning to debunk those conspiracy theories and spot the logical fallacies in your own thinking. This mindset shift helped me immensely. I also discovered Stoic philosophy, which taught me that I could choose not to react to emotional triggers and that no one could disturb my inner peace unless I allowed it—something I wasn't even aware was possible.
I believe many mental health challenges stem from the belief that we lack control over our thoughts and emotions. The truth is, you can train your brain. The mind is like a muscle; just as you wouldn’t expect to transform your body in a single day at the gym, strengthening your mind takes consistent effort and hard work. If you stick with it, you get stronger every day.
Challenging my negative self-talk was one of the hardest things I’ve ever done. After over a decade of habitual self-criticism, catastrophizing, and black-and-white thinking, breaking those thought patterns felt almost insurmountable. But this process—essentially cognitive behavioral therapy (CBT) in practice—was transformative. While a therapist trained in CBT can offer valuable guidance, real progress comes from consistently applying these strategies in your everyday life.
Through this work, I developed an internal locus of control and a sense of agency that had been missing for most of my life. For the first time, I no longer saw myself as mentally ill and destined for a life of failure: I felt like I was truly in charge of my thoughts, my actions, and my future.
Aftermath
I eventually reconnected with my family, and we’re very close now. While making friends became somewhat easier as I got older, maintaining those friendships remained a challenge. Throughout my twenties and early thirties, I still struggled with identity issues, which led to a somewhat unconventional life as I searched for direction. I moved frequently, even living in Switzerland at one point, changed my college major several times, changed my appearance often, worked as a caregiver for special needs children and adults, tagged along on tour with Alice Cooper, illustrated children’s books, and became a social justice meme-maker for a short time before undergoing a political realignment.
Clarity came at age 30, when I was assessed for and diagnosed with Asperger’s syndrome. This often presents differently in girls and can go undetected, as comorbidities tend to emerge around puberty, shifting the focus away from the underlying condition.
Hypersensitivity to light and sound, social difficulties, obsessive interests, repetitive behaviors, struggles with abstract thinking and executive functioning, auditory processing challenges, food intolerances, motor-balance issues, and possibly even the cerebellum abnormalities revealed in my MRI all finally seemed to fit into a cohesive narrative. However, I am now cautious not to let any diagnosis define my identity. Instead, I focus on accommodating myself to better manage the associated symptoms so that they don't interfere with the life I want.
Even after this revelation, my life still lacked purpose. It was only in recent years, after becoming a journalist, that I truly felt like I had found my calling. Journalism has given me a sense of accomplishment and self-worth. It’s an exciting career that allows me to leverage my strengths in research and writing, along with traits like hyper-focus, an obsessive drive to deeply understand topics, attention to detail, and the ability to work long hours without fatigue. It’s a profession where I can pursue my love of learning while helping others stay informed.
In my work with detransitioners, I conducted a survey revealing 85.7% reported that their healthcare providers, including doctors and therapists, described being transgender as a biological characteristic beyond their control—a medical condition necessitating treatment. Additionally, 49.2% recalled providers framing their transgender identity as a brain condition, using the phrase "male brain in a female body" and vice versa. This framing drew striking parallels to my own experience with the brain disease model of mental illness. Both present psychiatric conditions as innate and immutable traits, profoundly shaping young people's self-perception and undermining their sense of personal agency.
Learning about the history of psychiatry, combined with my personal experience, and the experiences of detransitioners, has really shaken my faith in the field, leading me to wonder if it deserves the outsized trust we place in it.
Diagnostic categories within the Diagnostic and Statistical Manual of Mental Disorders (DSM) reflect the opinions of appointed experts rather than being grounded in consistently replicated scientific research. Psychiatric diagnoses are often unreliable because they are based on subjective criteria, such as self-reports from patients, behavioral observations, and clinician interpretation, all of which are susceptible to bias and error. Recent research has highlighted a significant amount of overlap within DSM-defined disorder categories, leading some researchers to conclude that psychiatric diagnosis is "scientifically meaningless."
And yet, the DSM has become a globalizing force, spreading predominantly Western concepts of mental health to other cultures, often driven by the interests of pharmaceutical companies and professional organizations. This has contributed to the rise of diagnostic fads and diagnostic inflation, where increasingly broad criteria pathologize human behavior, labeling it as mental disorders.
We have to consider how the DSM serves as a powerful cultural script, and influences how we express and communicate our distress. While there is some utility in classifying mental and emotional distress, diagnoses are often misunderstood as the cause of a person’s struggles, leading many to define themselves by these labels. This can create a self-fulfilling prophecy, where belief in a diagnosis influences the manifestation of symptoms—even when the diagnosis is incorrect.
We need to step back from the brain disease model of mental illness and rethink how we understand life’s difficulties. Unwanted thoughts and emotions are not simply the result of abnormal brain chemistry requiring chemical correction. In many cases, they can be changed with effort and persistence—but that process begins by rejecting the idea that you lack the power to make those changes.
Mental illness should not be viewed as a permanent condition or a defining aspect of one's identity. Instead, it should be seen as something to work toward overcoming—to the extent it is possible. This perspective may not apply uniformly to all conditions, such as psychotic disorders, but in most cases, recovery even from serious mental illness is attainable. Believe you are sick, and you will be sick; believe you can get better, and you can.
![Tumblr media](https://64.media.tumblr.com/345d2d49792cc26603da0dbc1af8cbbf/68b7015ebcbac7d4-34/s500x750/68f2f715372eb9aba4a9a3579d2024c97c99a577.jpg)
#Christina Buttons#mental health#mental illness#mentally ill#internal locus#external locus#locus of control#identity#personal identity#brain disease#brain disease model#biomedical model#medical condition#religion is a mental illness
4 notes
·
View notes
Text
Strange Chinese trade-war recommendations at US Congress
COMPREHENSIVE LIST OF THE COMMISSION’S 2024 RECOMMENDATIONS Part II: Technology and Consumer Product Opportunities and Risks Chapter 3: U.S.-China Competition in Emerging Technologies The Commission recommends:
Congress establish and fund a Manhattan Project-like program dedicated to racing to and acquiring an Artificial General Intelligence (AGI) capability. AGI is generally defined as systems that are as good as or better than human capabilities across all cognitive domains and would surpass the sharpest human minds at every task. Among the specific actions the Commission recommends for Congress:
Provide broad multiyear contracting authority to the executive branch and associated funding for leading artificial intelligence, cloud, and data center companies and others to advance the stated policy at a pace and scale consistent with the goal of U.S. AGI leadership; and
Direct the U.S. secretary of defense to provide a Defense Priorities and Allocations System “DX Rating” to items in the artificial intelligence ecosystem to ensure this project receives national priority.
Congress consider legislation to:
Require prior approval and ongoing oversight of Chinese involvement in biotechnology companies engaged in operations in the United States, including research or other related transactions. Such approval and oversight operations shall be conducted by the U.S. Department of Health and Human Services in consultation with other appropriate governmental entities. In identifying the involvement of Chinese entities or interests in the U.S. biotechnology sector, Congress should include firms and persons: ○ Engaged in genomic research; ○ Evaluating and/or reporting on genetic data, including for medical or therapeutic purposes or ancestral documentation; ○ Participating in pharmaceutical development; ○ Involved with U.S. colleges and universities; and ○ Involved with federal, state, or local governments or agen cies and departments.
Support significant Federal Government investments in biotechnology in the United States and with U.S. entities at every level of the technology development cycle and supply chain, from basic research through product development and market deployment, including investments in intermediate services capacity and equipment manufacturing capacity.
To protect U.S. economic and national security interests, Congress consider legislation to restrict or ban the importation of certain technologies and services controlled by Chinese entities, including:
Autonomous humanoid robots with advanced capabilities of (i) dexterity, (ii) locomotion, and (iii) intelligence; and
Energy infrastructure products that involve remote servicing, maintenance, or monitoring capabilities, such as load balancing and other batteries supporting the electrical grid, batteries used as backup systems for industrial facilities and/ or critical infrastructure, and transformers and associated equipment.
Congress encourage the Administration’s ongoing rulemaking efforts regarding “connected vehicles” to cover industrial machinery, Internet of Things devices, appliances, and other connected devices produced by Chinese entities or including Chinese technologies that can be accessed, serviced, maintained, or updated remotely or through physical updates.
Congress enact legislation prohibiting granting seats on boards of directors and information rights to China-based investors in strategic technology sectors. Allowing foreign investors to hold seats and observer seats on the boards of U.S. technology start-ups provides them with sensitive strategic information, which could be leveraged to gain competitive advantages. Prohibiting this practice would protect intellectual property and ensure that U.S. technological advances are not compromised. It would also reduce the risk of corporate espionage, safeguarding America’s leadership in emerging technologies.
Congress establish that:
The U.S. government will unilaterally or with key interna- tional partners seek to vertically integrate in the develop- ment and commercialization of quantum technology.
Federal Government investments in quantum technology support every level of the technology development cycle and supply chain from basic research through product development and market deployment, including investments in intermediate services capacity.
The Office of Science and Technology Policy, in consultation with appropriate agencies and experts, develop a Quantum Technology Supply Chain Roadmap to ensure that the United States coordinates outbound investment, U.S. critical supply chain assessments, the activities of the Committee on Foreign Investment in the United States (CFIUS), and federally supported research activities to ensure that the United States, along with key allies and partners, will lead in this critical technology and not advance Chinese capabilities and development....
6 notes
·
View notes
Text
Once you know the history of Allopathic Medicine, you'll never see the medical world quite the same way again. Rationally speaking, we have much to do to Make America Health Again. Feel free to repost
James Lyons-Weiler
Dec 05, 2024
Founding Fraudsters: Prominent Founding Figures with Ties to Questionable Medical Practices
The late 19th and early 20th centuries represent a pivotal moment in the history of medicine. This era witnessed the rise of professional healthcare and pharmaceutical industries, yet it also bore the imprint of practices today deemed unscientific or outright fraudulent. Many key figures in this transformative period straddled the divide between groundbreaking advancements and methods that echoed the quackery of their time.
William Radam, a German immigrant to the United States, became a prominent yet controversial figure with his creation of "Radam's Microbe Killer." Radam claimed his solution could destroy all disease-causing microbes in the body, an assertion supported by fervent advertising campaigns. The product, a mixture of water, sulfuric acid, and red wine, was ineffective and potentially harmful. Yet, Radam’s marketing mastery—emphasizing dramatic claims of universal cures—foreshadowed the branding strategies that pharmaceutical companies would later refine, prioritizing trust and appeal over scientific evidence.
Similarly, Benjamin Brandreth, a New York-based entrepreneur, capitalized on public gullibility with his "Vegetable Universal Pills." Brandreth promised that these pills, composed primarily of cayenne pepper and other innocuous ingredients, could purify the blood and cure myriad ailments. Despite their lack of medical efficacy, the pills became a household staple, and Brandreth amassed a fortune. His success illustrated not only the public’s willingness to embrace unverified remedies but also the power of colorful, engaging advertising—a practice that became a cornerstone of pharmaceutical promotion.
2 notes
·
View notes
Text
Real-World Evidence/RWE Solutions Market Business Expansion Strategies
The Real-World Evidence (RWE) Solutions Market is experiencing substantial growth, driven by increasing regulatory support, rising R&D investments, and the shift towards value-based healthcare systems.
Market Overview
The RWE Solutions Market was valued at USD 2.5 billion in 2023 and is projected to grow at a Compound Annual Growth Rate (CAGR) of 8.5% from 2024 to 2032, reaching USD 5.2 billion by 2032.
Regional Analysis
North America currently leads the market, attributed to robust healthcare infrastructure and significant investments in RWE studies. Europe follows, with increasing adoption driven by supportive regulatory frameworks. The Asia-Pacific region is anticipated to witness the fastest growth, propelled by expanding healthcare sectors and rising focus on evidence-based medical practices.
Get free sample report @ https://www.snsinsider.com/sample-request/1787
Market Segmentation
The RWE Solutions Market is segmented based on:
Component: Services and Data Sets
Application: Drug Development and Approvals, Medical Device Development and Approvals, Reimbursement/Coverage and Regulatory Decision Making, and Others
Therapeutic Area: Oncology, Cardiology, Neurology, Diabetes, Psychiatry, Respiratory, and Other Therapeutic Areas
End-Use: Pharmaceutical & Biotechnology Companies, Medical Device Companies, Healthcare Providers, Healthcare Payers, and Others
Key Players
Major market players include Syneos Health, ICON plc, Clinigen Limited, IQVIA Inc., PerkinElmer Inc., Oracle, IBM, Medpace, PPD, Inc. (Acquired by Thermo Fisher Scientific, Inc.), Cognizant, Cegedim Health Data, Parexel International (MA) Corporation, SAS Institute Inc., Optum Inc., and others.
Key Highlights
Regulatory Support: Global regulatory bodies are increasingly incorporating RWE into decision-making processes, enhancing its credibility and application.
Technological Advancements: Integration of AI, ML, and IoT is revolutionizing data analysis, providing deeper insights and expediting drug development.
Collaborative Initiatives: Industry collaborations are fostering innovation, expanding RWE applications beyond traditional clinical trials.
Future Outlook
The future of the RWE Solutions Market appears promising, with expectations of continued growth driven by technological advancements and evolving regulatory frameworks. The integration of RWE into early-stage drug development and its application across various therapeutic areas are anticipated to enhance healthcare outcomes and optimize resource utilization. As stakeholders increasingly recognize the value of real-world insights, RWE solutions are set to become integral to healthcare decision-making processes.
Conclusion
The Real-World Evidence Solutions Market is on an upward trajectory, propelled by regulatory endorsements, technological innovations, and collaborative efforts within the industry. As the healthcare landscape continues to evolve towards evidence-based practices, RWE solutions are positioned to play a pivotal role in shaping the future of medical research and patient care.
Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Other Related Reports:
Pharmacy Benefit Management Market
Behavioral Health Software Market
Precision Medicine Software Market
#Real-World Evidence/RWE Solutions Market#Real-World Evidence/RWE Solutions Market Share#Real-World Evidence/RWE Solutions Market Size#Real-World Evidence/RWE Solutions Market Trends
0 notes
Text
Global Yeast Market Forecast: 8.9% CAGR Growth Through 2029, Surpassing USD 8.5 Billion
The global yeast market size, estimated to be valued at USD 5.5 billion in 2024, showcases a remarkable growth projection, anticipated to escalate to USD 8.5 billion by 2029, indicating a robust CAGR of 8.9% during the forecast period. The yeast market is a diverse and dynamic sector with applications spanning various industries, including food and beverage, pharmaceuticals, and agriculture.
Factors Driving the Yeast Market Growth
The bakery industry has seen significant growth globally, particularly in emerging economies, driven by urbanization and evolving consumer preferences. This expansion has resulted in a notable increase in yeast demand, a vital component in bread-making. Yeast acts as the leavening agent that facilitates fermentation, giving bread its desired texture. In emerging markets, the growing preference for convenient and affordable food options, including packaged bread and pastries, has further boosted yeast demand.
Data from Agriculture Canada highlights this trend, showing that bread sales in the US rose from USD 23,541 million in 2018 to USD 30,018 million in 2022. This increase reflects shifting consumer habits and growing bread consumption, particularly in the US. As bread remains a staple food for many, the demand for yeast, essential for fermentation and the development of bread’s texture and flavor, has surged accordingly.
As a result, yeast producers are expanding their production capacities to meet the growing needs of bakeries adapting to consumer preferences. With bread sales continuing to rise, the yeast market is expected to benefit further from the bakery industry’s expansion, both in the US and worldwide, as consumers increasingly turn to baked goods for convenience and satisfaction.
The Feed Sector’s Expanding Yest Market Share: A Focus on Enhanced Nutrition
The increasing demand for yeast-based feed solutions reflects a broader shift towards sustainable and efficient agricultural practices. With companies such as Phileo by Lesaffre (France) introducing innovative products like the Actisaf Sc 47 HR+ probiotic for the poultry sector, there’s a clear emphasis on meeting this demand through research-driven solutions. These yeast-based additives offer a range of benefits, including improved feed efficiency, enhanced gut health, and better nutrient digestibility, leading to improved animal performance and welfare. As such, investments in launching new yeast-based feed products not only cater to current market demands but also drive forward the industry’s commitment to innovation and sustainability.
Yeast Market Trends
Health and Wellness: Increasing consumer awareness about health benefits associated with yeast, such as probiotics in nutritional yeast, is driving market growth.
Rising Demand for Processed Foods: The growth in the processed food sector is fueling the demand for baker’s yeast and other yeast products.
Craft Brewing Boom: The rise of craft breweries has increased the demand for specialty and high-quality yeast strains.
Sustainable Solutions: Yeast is gaining attention as a sustainable alternative in various applications, including biofuels and biodegradable products.
Request Sample Pages
In North America, the US dominates the yeast market due to rising trade opportunities.
The rise in trade opportunities has positioned the United States as a dominant force in the yeast industry within North America. With a notable export volume of USD 147 million in 2022, the United States emerged as the sixth-largest exporter of Yeast globally, showcasing its significant presence in the international market. Notably, the main destinations for US Yeast exports include Canada, Mexico, and Japan, indicating a diverse reach across different regions. Moreover, the fastest-growing export markets for US Yeast, such as Canada, Italy, and Japan, highlight the country’s ability to capitalize on expanding trade avenues. Additionally, while the United States imports substantial amounts of Yeast, totaling USD 439 million in 2022, its status as the largest importer globally provides leverage in negotiating favorable trade terms and strengthening its position as a dominant player in the North American yeast market. This robust trade activity underscores the United States’ growing influence and competitiveness in the global Yeast trade landscape, particularly within the US region.
Top Yeast Companies
ADM (US)
Associated British Foods plc (UK)
Alltech (US)
AngelYeast Co., Ltd (China)
Lallemand Inc. (Canada)
ICC (Brazil)
Leiber (Germany)
Lesaffre (France)
Nisshin Seifun Group Inc (Japan)
Pacific Fermentation Ind. Ltd. (Canada)
Pak Holding (Turkiye)
Biorigin (Brazil)
Kemin Industries, Inc (US)
0 notes
Text
Synthetic Vitamin E Market Industry Report 2025-2033: Future Trends and Growth Analysis
Synthetic Vitamin E Market Trends, Challenges, and Opportunities
Market Overview
Rapid technical breakthroughs and changing market demands are driving a dynamic transformation inside the Synthetic Vitamin E Market. This research offers a strategic roadmap for companies looking to take advantage of new opportunities by giving a thorough analysis of industry trends, important growth drivers, and potential roadblocks. Our comprehensive data-driven insights and expert research, which spans the years 2024–2033, emphasize important factors like pricing dynamics, adoption patterns, product innovation, and regional market penetration
Market Insights
Projection: Synthetic Vitamin E Market is expected to grow at CAGR of 6.5% from 2024 to 2033.
Market Valuation: Estimated market value by 2033: $XXX billion.
Key Influencing Factors: Technological disruption, regulatory shifts, and evolving consumer preferences.
Get Sample Research Report: https://marketstrides.com/request-sample/synthetic-vitamin-e-market
Key Trends Changing the Synthetic Vitamin E Market Sector
Staying ahead in the Synthetic Vitamin E Market requires a deep understanding of the evolving landscape. Here are some transformative trends reshaping the industry:
Smart technologies and digital disruption
Automation and analytics powered by AI are revolutionizing productivity and client interaction.
Companies that use IoT and big data are becoming more competitive.
Growing Interest in Personalization and Customization
Businesses are being pushed to innovate by consumers' growing preference for customized solutions.
Increasing the level of customisation in product offers is revolutionary.
Tougher Regulations and Compliance Requirements
Cost structures and operational strategies are being impacted by new government regulations.
For long-term viability, compliance criteria must be adjusted.
Competitive Landscape: Who’s Dominating the Synthetic Vitamin E Market?
Making wise strategic decisions requires an understanding of the Synthetic Vitamin E Market competitive dynamics. This section explores the major forces influencing the sector and provides a thorough SWOT analysis of the top three to five important businesses.
DSM
BASF
Adisseo
NHU
Zhejiang Medicine
PKU HealthCare
Beisha
Zhejiang Langbo
Important Points to Remember:
Strategic moves:Recent collaborations, acquisitions, and mergers are examples of strategic moves.
Analysis of Market Share: The ways in which the largest companies are growing their power.
Growth Potential: Finding unexplored possibilities for interested parties.
Browse Details of Synthetic Vitamin E Market with TOC: https://marketstrides.com/report/synthetic-vitamin-e-market
Synthetic Vitamin E Market Segmentation: Identifying High-Impact Sectors
Understanding market segmentation allows businesses to tailor their strategies effectively. Our research breaks down the Synthetic Vitamin E Market based on:
Segment By Type
Synthetic Vitamin E Oil
Synthetic Vitamin E Power
Segment By Application
Food Industry
Pharmaceuticals
Feed Additives
Other
Regional Market Demand: Where Are the Biggest Opportunities?
Each region presents unique growth opportunities and challenges. This section provides a detailed breakdown of demand trends, regional dynamics, and factors influencing market expansion across different geographies.
North America
Europe
Asia-Pacific
Latin America
The Middle East and Africa
Buy Now:https://marketstrides.com/buyNow/synthetic-vitamin-e-market
Why Trust Our Research?
Unparalleled Data Accuracy – Verified sources, rigorous validation techniques.
Holistic Research Approach – Primary research (interviews, surveys) + secondary analysis.
Industry-Specific Expertise – Domain specialists ensure actionable insights.
AI-Powered Analytics – Cutting-edge tools for precise market forecasting.
Transparent & Ethical Practices – Unbiased reporting you can rely on.
Frequently Asked Questions (FAQs)
What is the projected growth rate of the Synthetic Vitamin E Market?
What are the key factors driving market expansion?
What challenges are hindering Synthetic Vitamin E Market growth?
How is the market segmented, and which segments show the most potential?
Which regions lead in Synthetic Vitamin E Market demand and why?
About Us
Market Strides is a trusted name in global market intelligence, offering research reports across diverse industries. We specialize in market sizing, competitive analysis, and trend forecasting, empowering businesses with the data-driven insights they need to make informed decisions.
Contact Us: [email protected]
0 notes
Text
MENA Syringes & Cannula Market: Key Growth Drivers and Future Outlook - UnivDatos
According to a new report by UnivDatos Market Insights, The MENA Syringes & Cannula Market was valued at USD 1,505.79 million in the year 2023 and is expected to grow at a strong CAGR of around 7.29% during the forecast period. Owing to the aging population is more vulnerable to illnesses that require hospitalization and medical procedures that involve syringes and cannula. As per the United Nations Population Fund (UNFPA), in 2024, the United Arab Emirates is going through a demographic transition as the number of persons aged 60+ is expected to increase more than six-fold between 2020 - 2050 from about 311,000 (3.1% of the total population) to 2 million (19.7%). Adding to this, the increased rate of diabetes, cardiovascular diseases, and other chronic diseases led to other increased frequency of standard medical procedures. Furthermore, the use of devices like cannula for surgeries and treatments has increased as medical procedures have advanced.
Request To Download Sample of This Strategic Report - https://univdatos.com/reports/causal-ai-market?popup=report-enquiry&utm_source=LinkSJ&utm_medium=Snehal&utm_campaign=Snehal&utm_id=snehal
The report suggests that Syringes & Cannula resources in the MENA region had a significant impact on the Syringes & Cannula industry in the MENA region. Some of how this impact has been felt include:
· In April 2024: Medline announced it has entered into a definitive agreement to acquire Ecolab, Inc.'s global surgical solutions business, including the industry-leading Microtek product lines. Once closed, the acquisition will provide Medline with innovative sterile drape solutions for surgeons, patients, operating room equipment, and Ecolab’s fluid temperature management system.
· In May 2023, Pfizer and Thermo Fisher Scientific Inc. announced they have entered into a collaboration agreement to help increase local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients in more than 30 countries across Latin America, Africa, the Middle East and Asia where advanced genomic testing has previously been limited or unavailable.
· In February 2021, the Advanced Medical Technology Association (AdvaMed) inked a MoU, entering a formal relationship with MECOMED, MEA’s medical devices, imaging, and diagnostics trade association. The collaboration facilitated information sharing between both organizations and increased the ability to strengthen this market.
· In May 2021, Medovate, a medical device manufacturer in the U.K., announced a partnership in the Middle East. The Cambridge-based specialist has teamed up with Kuwait’s Omneya Medical Co. to distribute its SAFIRA (SAFer Injection for Regional Anesthesia) device in the Gulf country.
Apart from this, in recent years, UAE has significant growth in MENA, and North Africa has enhanced the growth of the Syringes & Cannula industry:
The UAE is expected to grow with a significant CAGR during the forecast period (2024-2032). The market of syringes and cannula in UAE is consequently driven by government initiatives to enhance healthcare and construct better healthcare facilities. The current government’s investment in health under Vision 2021 has emphasized quality health facilities that depend majorly on medical disposables for the overall safe course of medical practice. For instance, in October 2022, the Ministry of Industry and Advanced Technology (MoIAT) announced the signing of a pair of MoU worth Dh 260 million (USD 7 million) between major pharmaceutical companies and medical devices companies in the United Arab Emirates. The UAE has a well-developed healthcare sector featuring modern hospitals and clinics generating demand for superior medical consumables like syringes and cannula. In addition, the UAE is one of the prominent medical tourism destinations in the region, hosting patients from all corners of the world and adding to the demand for medical devices and supplies.
Ask for Report Customization - https://univdatos.com/reports/causal-ai-market?popup=report-enquiry&utm_source=LinkSJ&utm_medium=Snehal&utm_campaign=Snehal&utm_id=snehal
Conclusion
In conclusion, Syringes & Cannula market in the MENA region is anticipated to show considerable growth in the future due to strategic healthcare investments and increasing incidences of chronic diseases. It was found that technological factors are indeed crucial, of which the move towards safer and more efficient medical device is prominent. However, one of the major issues facing the market players is the operationalization of these diverse regulatory frameworks regarding renewable energy implementation within the different countries of the MENA region. Therefore, in the future, the focus must be on long-term development and marketing, investing in innovation and compliance to capture new opportunities and maintain the scale of competitiveness in this evolving and growing healthcare market.
0 notes
Text
The Industrial Solar Water Heaters Market is projected to grow from USD 806.8 million in 2024 to an estimated USD 1121.26 million by 2032, with a compound annual growth rate (CAGR) of 4.2% from 2024 to 2032.The global push towards renewable energy and sustainable practices has led to significant growth in the industrial solar water heaters market. Solar water heaters (SWH) are an environmentally friendly and cost-effective solution for heating water in industrial settings, where energy demand is often high. This market is being propelled by increasing environmental awareness, supportive government policies, and advancements in solar technology.
Browse the full report at https://www.credenceresearch.com/report/industrial-solar-water-heaters-market
Market Overview
Industrial solar water heaters are used extensively in sectors such as food processing, textiles, chemicals, pharmaceuticals, and hospitality, where hot water is essential for operations. These systems harness solar energy to heat water, reducing reliance on fossil fuels and lowering carbon footprints.
In recent years, the global industrial solar water heaters market has experienced steady growth due to rising energy costs and a heightened focus on renewable energy sources. According to market reports, the sector is poised for exponential expansion, driven by increasing adoption in both developed and developing economies.
Key Drivers of Growth
Environmental Concerns: Governments worldwide are promoting the adoption of renewable energy technologies to combat climate change. Solar water heaters help industries reduce greenhouse gas emissions, aligning with global sustainability goals.
Rising Energy Costs: With traditional energy sources becoming more expensive, industries are turning to solar water heaters as a long-term, cost-effective solution.
Technological Advancements: Innovations in solar panel efficiency, thermal insulation, and storage systems have made industrial solar water heaters more reliable and efficient.
Supportive Policies: Subsidies, tax benefits, and incentives for adopting solar technologies are encouraging industries to make the shift. Countries such as China, India, and the United States have implemented policies that facilitate the adoption of solar water heating systems.
Market Challenges
Despite its growth, the market faces certain challenges:
High Initial Investment: While solar water heaters offer long-term savings, the upfront installation cost can be a deterrent for small and medium-sized enterprises (SMEs).
Weather Dependency: The efficiency of solar water heaters is highly dependent on sunlight availability, making them less effective in regions with prolonged cloudy or cold weather.
Maintenance Requirements: Regular maintenance is essential to ensure optimal performance, which may add to operational costs.
Future Outlook
The industrial solar water heaters market is set to grow at a robust pace, with increasing demand from industries aiming to reduce their energy costs and environmental impact. Emerging trends such as hybrid systems combining solar water heaters with conventional energy sources and smart monitoring technologies are expected to further drive the market.
As industries continue to prioritize sustainability, the adoption of solar water heating systems is likely to become an integral part of their operations. With ongoing innovations and supportive policies, the market’s potential remains immense, paving the way for a greener future.
Key Player Analysis:
O. Smith Corporation
Alternate Energy Technologies LLC
American Water Heaters
Apricus Solar Co. Ltd.
Ariston Thermo Group
ATR SOLAR
Azure Power India
Bosch Thermotechnology
Chandrlok International
Chromagen
Excel Innovations Private Limited.
Greentek India Pvt. Ltd.
Heliodyne, Inc.
Himin Solar Co. Ltd.
Jinyi Solar Energy Technology Co., Ltd.
Panasonic Corporation
Racold
Rheem Manufacturing Company
SunEarth Inc.
SunMaxx Solar
SUNPEAK USA Inc.
Viessmann Group
Segmentation:
By Industry Type:
Small Scale
Medium Scale
Large Scale
By Sales Channel:
Sales via Original Equipment Manufacturers
Sales via Aftermarket
By End Use:
For Automotive
For Construction
For Oil & Gas
For Paints & Coatings
For Other End Uses(Refractory, Bulk Fillers, Etc.)
By Region:
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa
Browse the full report at https://www.credenceresearch.com/report/industrial-solar-water-heaters-market
Contact:
Credence Research
Please contact us at +91 6232 49 3207
Email: [email protected]
0 notes
Text
Printed Carton Market Growth: Share, Value, Size, Scope, and Insights
"Printed Carton Market Size And Forecast by 2032
The Printed Carton Market is a rapidly expanding industry that plays a critical role in shaping global economic dynamics. With its remarkable size, share, and scope, the market has become a focal point for innovation, investment, and growth. This comprehensive research report delves into the market's evolution, offering insights into its current performance and future outlook. It examines key factors such as demand, growth drivers, and revenue trends that are shaping the industry's trajectory.
The global printed carton market size was valued at USD 389.08 billion in 2024 and is projected to reach USD 601.66 billion by 2032, with a CAGR of 5.60% during the forecast period of 2025 to 2032.
Get a Sample PDF of Report - https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-printed-carton-market
Which are the top companies operating in the Printed Carton Market?
The Top 10 Companies in Printed Carton Market are prominent players known for their leadership and innovation. These include companies recognized for their strong product offerings and market influence. These companies have built solid reputations through their commitment to quality, customer satisfaction, and staying ahead of industry trends, making them key competitors in the Printed Carton Market.
**Segments**
- Based on material types, the global printed carton market can be segmented into paperboard, corrugated board, and others. Paperboard is widely used due to its sustainability and recyclability as well as its ability to provide high-quality printing surfaces. Corrugated board, on the other hand, is preferred for shipping purposes due to its strength and durability. The others segment includes materials like plastic, metal, and wood, but these have a smaller market share in the printed carton industry.
- By printing ink type, the market can be segmented into water-based ink, UV-curable ink, and others. Water-based ink is eco-friendly and suitable for food packaging, making it a popular choice. UV-curable ink offers fast curing times and high-quality printing but may not be as sustainable as water-based ink. The others segment includes solvent-based ink and oil-based ink, which are less commonly used in the market.
- On the basis of end-users, the market can be segmented into food & beverage, healthcare, personal care & cosmetics, household care, and others. The food & beverage industry dominates the printed carton market due to the high demand for attractive packaging for food products. The healthcare sector also contributes significantly to the market, as printed cartons are essential for packaging pharmaceuticals and medical supplies securely. The personal care & cosmetics industry values printed cartons for their branding and marketing capabilities.
**Market Players**
- Some key players in the global printed carton market include WestRock Company, International Paper, DS Smith, Mondi, Smurfit Kappa, Georgia-Pacific, Mayr-Melnhof Karton, Stora Enso, Oji Holdings Corporation, and Amcor. WestRock Company is a leading player known for its innovative packaging solutions and sustainable practices. International Paper is another major player with a wide range of paper and packaging products. DS Smith focuses on providing sustainable packaging solutions to its customers, aligning with the market trends towards eco-friendly materials. Mondi is renowned for its customer-centric approach and expertise in paper and packaging. Smurfit Kappa is a global player with a strong emphasis on recyclable and biodegradable packaging solutions. These market players, among others, drive the competition and innovation in the global printed carton market.
https://www.databridgemarketresearch.com/reports/global-printed-carton-marketThe global printed carton market is experiencing a shift towards more sustainable and eco-friendly practices driven by consumer preferences and regulatory pressures. Market players are increasingly focusing on developing packaging solutions that are recyclable, biodegradable, and made from renewable materials. This trend is leading to innovations in materials, printing technologies, and design concepts within the printed carton industry. As consumers become more environmentally conscious, there is a growing demand for packaging that reflects these values, pushing companies to adopt greener practices in their packaging solutions.
One key trend influencing the market is the rise of personalized and customized packaging solutions. Brands are leveraging digital printing technologies to create unique and tailored packaging for their products, enhancing brand recognition and customer engagement. Personalized packaging not only helps brands stand out on the shelf but also facilitates storytelling and brand communication, connecting with consumers on a deeper level. This trend is driving the adoption of digital printing technologies in the printed carton market, enabling shorter print runs and faster turnaround times for customized packaging solutions.
Moreover, the integration of smart packaging technologies is another emerging trend in the printed carton market. Smart packaging solutions incorporate features such as QR codes, NFC tags, and RFID sensors to provide product traceability, authenticity verification, and interactive consumer experiences. These technologies allow brands to gather valuable data on consumer behavior and preferences, enabling targeted marketing strategies and enhancing overall customer satisfaction. As e-commerce continues to grow, smart packaging solutions also play a crucial role in improving supply chain visibility and logistics efficiency.
Additionally, the COVID-19 pandemic has had a significant impact on the printed carton market, accelerating the shift towards online shopping and home deliveries. With more consumers opting for e-commerce platforms, there is a greater demand for durable and protective packaging solutions to ensure the safe delivery of products. Printed cartons play a vital role in this scenario by providing branding opportunities, product information, and protection during transit. As the e-commerce sector continues to expand, the printed carton market is expected to witness sustained growth in the coming years, driven by the increasing need for reliable and visually appealing packaging solutions in the digital retail landscape.
In conclusion, the global printed carton market is evolving to meet the changing demands of consumers, brands, and regulations. Sustainable practices, personalized packaging solutions, smart technologies, and the impact of the pandemic are shaping the future of the industry. Market players are adapting to these trends by investing in innovation, digitalization, and sustainability to stay competitive and meet the evolving needs of the market. The printed carton sector is poised for growth and transformation as it continues to play a critical role in the packaging ecosystem across various industries.**Segments**
Global Printed Carton Market, By Material Type (Paper Board, Corrugated Board, Kraft Board, Coated Paper, Liquid Board), Feature (Disposable, Bio-degradable, Recyclable), End User (Food and Beverage, Hardware and Electronics, Homecare, Healthcare, Cosmetics and Personal Care, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, U.A.E, Saudi Arabia, Egypt, South Africa, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2032
- Paperboard is the preferred material type in the printed carton market due to its sustainability and recyclability, providing high-quality printing surfaces for attractive packaging solutions. - Corrugated board finds its strength and durability advantageous for shipping purposes, ensuring secure packaging during transit. - Different features such as disposable, bio-degradable, and recyclable are being emphasized in the industry to align with the sustainability trends and consumer preferences. - End users like the food and beverage industry, healthcare sector, personal care & cosmetics, household care, and others drive the demand for printed cartons across various sectors. - The market is segmented by country to analyze regional trends and opportunities in the global printed carton market, taking into account factors like material preferences and end-user demands.
**Market Players**
The major players covered in the printed carton market report are ALL PACKAGING COMPANY, Amcor plc, Ariba & Company, DS Smith, Huhtamaki Oyj, SIG Combibloc Group Ltd, Winston Packaging, Smurfit Kappa, WestRock Company, Tetra Pak, Mondi, Glossop Cartons, Webpac, Elopak AS, Georgia-Pacific, Evergreen Packaging LLC, Parksons Packaging Ltd., TCPL Packaging Limited, Gulf Carton Factory Co., Keystone Paper & Box Company, Inc., LGR Packaging and International Paper, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The global printed carton market is witnessing a significant shift towards more sustainable practices, driven by consumer preferences and regulatory pressures. Market players are focusing on developing packaging solutions that are recyclable, biodegradable, and made from renewable materials to align with environmental concerns. Personalized packaging solutions and the integration of smart technologies are emerging trends shaping the industry. Brands are leveraging digital printing technologies to create unique packaging designs, enhancing brand recognition and customer engagement. Smart packaging solutions incorporating QR codes, NFC tags, and RFID sensors provide product traceability and interactive consumer experiences. The impact of the COVID-19 pandemic has accelerated the adoption of e-commerce, leading to a higher demand for durable and protective packaging solutions to ensure safe product delivery. The printed carton market is poised for continued growth as companies innovate in sustainability, customization, and smart packaging technologies to meet evolving market needs across various industries.
Explore Further Details about This Research Printed Carton Market Report https://www.databridgemarketresearch.com/reports/global-printed-carton-market
Key Insights from the Global Printed Carton Market :
Comprehensive Market Overview: The Printed Carton Market is experiencing robust growth driven by technological advancements and increasing consumer demand.
Industry Trends and Projections: The market is projected to expand at a CAGR of X% over the next five years, with a significant shift towards sustainability.
Emerging Opportunities: Growing demand for innovative products and services presents new business opportunities in niche segments.
Focus on R&D: Companies are investing heavily in research and development to stay ahead in a competitive market landscape.
Leading Player Profiles: Key players include known for their market leadership and innovation.
Market Composition: The market is fragmented, with both large corporations and small enterprises playing vital roles.
Revenue Growth: The market has seen a steady increase in revenue, driven by strong consumer adoption and product diversification.
Commercial Opportunities: Businesses can capitalize on untapped regional markets and technological advancements to gain a competitive edge.
Find Country based languages on reports:
https://www.databridgemarketresearch.com/jp/reports/global-printed-carton-markethttps://www.databridgemarketresearch.com/zh/reports/global-printed-carton-markethttps://www.databridgemarketresearch.com/ar/reports/global-printed-carton-markethttps://www.databridgemarketresearch.com/pt/reports/global-printed-carton-markethttps://www.databridgemarketresearch.com/de/reports/global-printed-carton-markethttps://www.databridgemarketresearch.com/fr/reports/global-printed-carton-markethttps://www.databridgemarketresearch.com/es/reports/global-printed-carton-markethttps://www.databridgemarketresearch.com/ko/reports/global-printed-carton-markethttps://www.databridgemarketresearch.com/ru/reports/global-printed-carton-market
Data Bridge Market Research:
Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC: +653 1251 975
Email:- [email protected]"
0 notes
Text
Carnauba Wax: Natural Solutions for Cosmetics, Automotive, and More
![Tumblr media](https://64.media.tumblr.com/0ab06fa73eba48f90ce2cf5d6d9330a4/232f743921ee48f2-66/s540x810/619bca66042c293a5742fdc74fdb86dde18b19e0.jpg)
Carnauba Wax Market Set to Expand with Robust Growth Through 2033 - Straits Research
Report Overview: The global carnauba wax market is projected to experience significant growth over the forecast period from 2025 to 2033. Valued at USD 310 million in 2024, the market is expected to grow from USD 350 million in 2025 to USD 590 million by 2033, at a compound annual growth rate (CAGR) of 6.8%. This market expansion is fueled by the increasing demand for natural and sustainable products across key industries, including food, cosmetics, pharmaceuticals, and automotive.
Market Overview: Carnauba wax is a natural, sustainable wax derived from the leaves of the carnauba palm tree, native to Brazil. With its high melting point, glossy finish, and hypoallergenic properties, it is widely used in premium applications such as food coatings, personal care products, and automotive polishes. As consumers and businesses shift toward eco-friendly and non-toxic alternatives, carnauba wax has emerged as a key ingredient in clean-label and sustainable formulations.
Request a Free Sample (Free Executive Summary at Full Report Starting from USD 1850): https://straitsresearch.com/report/carnauba-wax-market/request-sample
Market Dynamics: The global trend toward sustainability has played a crucial role in driving the demand for carnauba wax. The rise of eco-conscious consumers seeking natural, biodegradable ingredients has seen a surge in the use of carnauba wax in cosmetics, food, and pharmaceuticals. Additionally, its application in the automotive industry as a car polish and finish further propels the market. Notable examples include AkzoNobel's use of carnauba wax in eco-friendly wood coatings, highlighting the wax's versatility.
Key Segments:
By Product Type:
Cosmetics and Personal Care: This segment leads the market as carnauba wax is widely used in lip balms, mascaras, and other beauty products.
Food and Beverages: Carnauba wax serves as a glazing agent in food applications such as candies, fruits, and chewing gum.
Pharmaceuticals: Its increasing use as an excipient in controlled-release drug formulations presents growth opportunities.
By Application:
Food Coatings: The food industry is the largest consumer of carnauba wax for its ability to enhance shelf life and product appearance.
Vehicle Polishes: The automotive sector remains a significant end-user, with demand for premium car care products growing steadily.
By End-User:
Cosmetics Manufacturers: As part of the clean beauty movement, cosmetics manufacturers are integrating carnauba wax into formulations to meet rising demand for natural ingredients.
Food Manufacturers: The increasing shift toward organic and clean-label products is driving the growth of carnauba wax in the food industry.
Market Segmentation with Insights-Driven Strategy Guide: https://straitsresearch.com/report/carnauba-wax-market/segmentation
Regional Insights:
North America: Dominates the global market due to strong demand from cosmetics and food industries, along with regulatory support for sustainable products.
Europe: Growing demand for carnauba wax, particularly driven by consumer preferences for organic products and eco-friendly regulations.
Asia-Pacific: The fastest-growing market, fueled by industrial expansion in China, India, and Japan. Rising consumer awareness of sustainability drives carnauba wax adoption, particularly in cosmetics and food.
LATAM: Brazil, where carnauba wax is sourced, plays a central role in the market's growth, aided by government initiatives supporting sustainable harvesting practices.
Buy Full Report (Exclusive Insights with In-Depth Data Supplement): https://straitsresearch.com/buy-now/carnauba-wax-market
Key Players: The market is highly competitive, with key players including:
Koster Keunen
BASF SE
Foncepi
Strahl and Pitsch
Akrochem Corporation
Norevo GmbH
Paramelt
Tropical Ceras
Carnauba do Brasil
These players are focusing on product innovation, expanding production capabilities, and catering to the growing demand for sustainable and biodegradable products.
Recent Developments:
In August 2024, BASF launched a new carnauba wax-based coating for the automotive industry, offering enhanced durability and a glossy finish.
In November 2024, Tropical Cera expanded its processing facilities in Brazil to meet increasing global demand, employing advanced filtration technologies to ensure high-quality production with minimal environmental impact.
To purchase the report: https://straitsresearch.com/buy-now/carnauba-wax-market
Challenges and Opportunities: Despite the growth prospects, the market faces challenges due to the volatility of raw material supply, as carnauba wax is primarily sourced from Brazil, where harvests can be impacted by climatic factors. However, the increasing consumer preference for natural, non-toxic ingredients presents long-term opportunities, especially in emerging markets such as Asia-Pacific and LATAM.
About Straits Research
Straits Research is a premier provider of market intelligence and analytics, offering in-depth research, advisory services, and comprehensive industry reports.
Contact Us:
Email: [email protected]
Address: 825 3rd Avenue, New York, NY, USA, 10022
Phone: +1 646 905 0080 (US), +91 8087085354 (India), +44 203 695 0070 (UK)
#carnauba wax#natural wax#cosmetics#automotive products#food coating#wax industry#eco-friendly#Brazilian wax
0 notes
Text
Pharma's Crippling Addiction and How to Cure it
NE - Naked Emperor Newsletter
Dec 04, 2024
Remember to add your book recommendations in the comments below.
Today’s book is:
Find It, File It, Flog It: Pharma's Crippling Addiction and How to Cure it by Hedley Rees
There are numerous books on the market that skewer Big Pharma, but they really only scratch the surface of a deep-seated affliction.
Find It, File It, Flog It: Big Pharma’s Crippling Addiction and How to Cure It examines an industry model that has not changed since the 1950s and offers practicable solutions for transforming it.
Author and supply chain management consultant Hedley G. Rees has firsthand experience with the industry. In an engaging style that speaks to a wide audience, he explains how pharmaceutical companies are addicted to the big profits that come from rushing drugs through the regulatory pipeline, aggressively marketing them—and gambling with people’s lives.
It doesn’t have to be this way. Providing facts, personal opinions, and the voices of expert witnesses for a broader perspective, Find It, File It, Flog It seeks to put patients—the ultimate beneficiaries of modern medicine—back in control of their destinies.
You can buy the book here (Amazon link).
2 notes
·
View notes
Link
0 notes
Text
Cell & Gene Therapy Manufacturing Services Market: Growth Opportunities for New Entrants
The global Cell & Gene Therapy Manufacturing Services Market is experiencing significant growth, driven by advancements in therapeutic approaches for life-threatening and rare diseases. Valued at USD 11.4 billion in 2023, the market is projected to reach USD 70.7 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 22.4% over the forecast period 2024-2032.
Market Segmentation:
The market is segmented based on therapy type, manufacturing scale, manufacturing mode, workflow, and region.
By Therapy Type:
Cell Therapy Manufacturing
Gene Therapy Manufacturing
By Manufacturing Scale:
Preclinical
Clinical
Commercial
By Manufacturing Mode:
In-House Manufacturing
Contract Manufacturing
By Workflow:
Vector Production
Cell Banking
Process Development
Fill & Finish Operations
Analytical & Quality Testing
Get Free Sample Report @ https://www.snsinsider.com/sample-request/1187
Regional Analysis:
North America: Leading the market due to substantial investments in gene therapy companies and a high number of ongoing clinical trials.
Europe: Experiencing growth driven by increased R&D activities and supportive regulatory frameworks.
Asia-Pacific: Anticipated to witness rapid growth owing to rising prevalence of target diseases and expanding healthcare infrastructure.
Key Players
Cellular Therapeutics
Lonza
Bluebird Bio Inc.
Thermo Fisher Scientific
Samsung Biologics
Boehringer Ingelheim
Hitachi Chemical Co., Ltd.
Takara Bio Inc.
Catalent Inc.
Miltenyi Biotec
F. Hoffmann-La Roche Ltd
Novartis AG
Merck KGaA
Wuxi Advanced Therapies and others.
Key Highlights:
As of May 2022, there were 329 cell and gene therapies undergoing clinical trials, with numbers expected to rise due to improved scientific understanding and clinical practices.
Approximately USD 2.3 billion has been invested in gene therapy companies over the past decade, indicating strong commitment from global pharmaceutical and biotechnology firms.
The increasing prevalence of cancer and other target diseases, along with heightened R&D spending by pharmaceutical companies, is propelling market growth.
Future Outlook:
The Cell & Gene Therapy Manufacturing Services Market is poised for substantial expansion, driven by the rising incidence of diseases such as cancer and orthopedic disorders, which necessitate innovative treatment solutions. The establishment of new manufacturing facilities and advancements in therapeutic approaches are expected to further fuel market growth. However, challenges such as high operational costs and the need for specialized infrastructure may impact the pace of expansion.
Conclusion:
The global Cell & Gene Therapy Manufacturing Services Market is on a robust growth trajectory, with significant developments across various segments and regions. Stakeholders, including manufacturers, healthcare providers, and investors, are well-positioned to benefit from the evolving landscape of cell and gene therapy manufacturing services.
Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Other Related Reports:
Medical Display Market Size
Medical Waste Containers Market Size
IoT Medical Devices Market Size
eClinical Solutions Market
#Cell & Gene Therapy Manufacturing Services Market#Cell & Gene Therapy Manufacturing Services Market Share#Cell & Gene Therapy Manufacturing Services Market Size#Cell & Gene Therapy Manufacturing Services Market Trends#Cell & Gene Therapy Manufacturing Services Market Growth
0 notes
Text
The Rise of Sustainable Aquaculture: Market Size and Trends to Watch (2025-2034)
![Tumblr media](https://64.media.tumblr.com/9f375d8488249f98baaa3d49b52ee797/f5a991dd205e841b-97/s540x810/d19533933480e3fbc86412daa63adbfca07b9183.jpg)
The Aquaculture Market was valued at USD 157.95 billion in 2023 and is poised for substantial growth over the coming years. The industry is projected to expand from USD 160.9 billion in 2024 to USD 262.09 billion by 2032, reflecting a robust compound annual growth rate (CAGR) of 6.29% during the forecast period (2024-2032). The rising demand for fish oil across various sectors, including food and beverages, pharmaceuticals, and nutraceuticals, along with the expansion of commercial seafood operations, are key drivers propelling market growth.
Market Drivers
Rising Demand for Fish Oil: The growing use of fish oil in health supplements, pharmaceuticals, and functional foods is fueling market demand.
Expanding Global Seafood Consumption: Increasing global population and rising health awareness have led to a surge in seafood consumption.
Technological Advancements in Aquaculture: Innovations in aquaculture practices, including sustainable and efficient farming techniques, are enhancing productivity.
Key Market Dynamics
Growth Factors: Government initiatives supporting sustainable aquaculture practices and the adoption of modern technologies are key growth enablers.
Challenges: Environmental concerns, disease outbreaks, and stringent regulatory frameworks pose significant challenges.
Trends: The shift towards eco-friendly aquaculture practices and the rising popularity of plant-based fish feed alternatives.
Key Market Opportunities
Sustainable Aquaculture Practices: Increasing focus on environmentally friendly and sustainable farming techniques.
Expansion into Emerging Markets: Growing opportunities in developing countries with untapped aquaculture potential.
Diversification of Aquaculture Species: Rising interest in farming diverse species beyond traditional fish, such as shellfish and seaweed.
Market Segmentation
By Environment:
Freshwater Aquaculture
Marine Aquaculture
Brackish Water Aquaculture
By Species:
Fish (Salmon, Carp, Tilapia, Catfish, etc.)
Crustaceans (Shrimp, Crab, etc.)
Mollusks (Oysters, Mussels, etc.)
Others (Seaweed, Algae, etc.)
By Application:
Food Industry
Pharmaceuticals
Nutraceuticals
Cosmetics
Segment Insights
Freshwater Aquaculture dominates due to its lower operational costs and widespread adoption in developing regions.
Fish Segment holds the largest share, with salmon and tilapia leading due to their high demand and nutritional benefits.
Food Industry remains the largest application segment, driven by increasing seafood consumption worldwide.
Key Players in the Market
Mowi ASA
Leroy Seafood Group
Cermaq Group AS
Thai Union Group
Nippon Suisan Kaisha, Ltd.
Blue Ridge Aquaculture, Inc.
Stolt-Nielsen Limited
Grieg Seafood ASA
Austevoll Seafood ASA
Bakkafrost
Regions Covered
Asia-Pacific: The largest market due to high seafood consumption and extensive aquaculture operations, especially in China and India.
North America: Growing due to increasing demand for sustainable seafood and technological innovations.
Europe: Focused on sustainable aquaculture practices and high-quality seafood products.
Latin America: Expanding rapidly with increasing seafood exports and favorable climatic conditions.
Middle East & Africa: Moderate growth driven by government initiatives to boost aquaculture production.
The Aquaculture Market is set for significant expansion, supported by rising global seafood demand, technological advancements, and sustainable farming practices.
Discover more Research Reports on Food and Beverages Industry, by Market Research Future:
Agricultural Bactericides MarketResearch Report Information By Type (Copper-Based Bactericides, Amide Bactericides, Dithiocarbamate Bactericides, And Others), By Form (Dry and Liquid), By Crop Type (Fruits & Vegetables, Cereals & Grains, Oilseeds & Pulses, And Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2034
Feed Supplements Market Research Report Information By Type (Protein, Vitamin, Amino Acid, Fatty Acid, Minerals, and Others), By Form (Dry, Liquid, and Others), By Livestock (Ruminants, Poultry, Swine, Aquaculture, and Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2034
Pet Food MarketAnalysis & Size, Share Research Report Information By Pet Type (Cat, Dog, Fish, and Others), By Product Type (Dry Food, Wet Food, and Snacks & Treats), By Distribution Channel (Store-Based and Non-Store-Based), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030
Aquaculture Market Research Report Information By Environment (Freshwater, Marine Water, and Brackish Water), By Type (Fishes, Crustaceans, Mollusca, and Others), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) - Forecast Till 2032
Ornamental Fish Feed Market Research Report Information By Type (Processed Feed and Live Feed), By Fish Type (Tropical Fishes, Goldfish, Koi, and Others), By Distribution Channel (Store-Based and Non-Store-Based), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) – Market Forecast Till 2032
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis about diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
0 notes